Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified Neoadjuvant Chemoradiotherapy in Chemotherapy-Resistant Adenocarcinomas of the Gastroesophageal Junction
NCT02287129Phase 2Completed
- Sponsor
- Technical University of Munich
- Start
- Dec 2014
- Primary completion
- Aug 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in adenocarcinoma of the esophagogastric junction (AEG), sponsored by Technical University of Munich. Started Dec 2014; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
adenocarcinoma of the esophagogastric junction (AEG)
Beyond the preview
Go deeper on NCT02287129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02287129.